Position in ABBV
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$3,628,900
+$409,831 QoQ
Shares Held
14,421
-2.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.89%
of 13F equity value
Holder Rank
#1,519
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Inlet Private Wealth, LLC holds $22,879,991 across 7 Drug Manufacturers - General names. ABBV ranks #4 (15.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
18,994 | $6,878,107 | |
| 2 | MRK |
Merck & Co., Inc.
|
51,190 | $6,577,915 | |
| 3 | JNJ |
Johnson & Johnson
|
15,948 | $4,050,313 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
14,421 | $3,628,900 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
17,331 | $998,612 | |
| 6 | SNY |
Sanofi
|
12,700 | $541,782 | |
| 7 | NVS |
Novartis AG
|
1,304 | $204,362 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,628,900 | 14,421 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $3,219,069 | 14,801 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $3,747,464 | 16,401 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $3,936,411 | 17,001 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $3,147,001 | 16,954 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $3,552,202 | 16,954 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $3,012,725 | 16,954 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $3,251,903 | 16,467 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $2,824,419 | 16,467 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $2,907,590 | 15,967 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $2,475,955 | 15,977 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $2,441,155 | 16,377 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $3,964,295 | 29,424 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $4,623,801 | 29,013 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $4,737,273 | 29,313 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $3,983,218 | 29,679 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $4,484,218 | 29,278 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $4,761,332 | 29,371 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $3,947,722 | 29,156 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $3,137,830 | 29,089 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,276,584 | 29,089 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $3,143,249 | 29,045 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $2,895,835 | 27,026 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $2,178,888 | 24,876 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $2,442,325 | 24,876 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $1,886,083 | 24,755 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||